PembrolizumabMyasthenia gravis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1764卷 / 1期

关键词：

D O I：

10.1007/s40278-019-65692-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：268 / 268

相关论文

共 50 条

[21] PembrolizumabMyasthenia gravis: case report
Reactions Weekly, 2017, 1658 (1) : 374 - 374
[22] PembrolizumabMyasthenia gravis: case report
Reactions Weekly, 2022, 1932 (1) : 497 - 497
[23] PembrolizumabMyasthenia gravis and myositis: case report
Reactions Weekly, 2025, 2046 (1) : 341 - 341
[24] PembrolizumabMyasthenia gravis and myositis: case report
Reactions Weekly, 2019, 1775 (1) : 377 - 377
[25] Nivolumab/pembrolizumabMyasthenia gravis: case report
Reactions Weekly, 2019, 1751 (1) : 300 - 300
[26] PembrolizumabMyasthenia gravis exacerbation: case report
Reactions Weekly, 2016, 1621 (1) : 202 - 202
[27] PembrolizumabMyasthenia gravis relapse: case report
Reactions Weekly, 2023, 1970 (1) : 237 - 237
[28] PembrolizumabMyasthenia gravis crisis: case report
Reactions Weekly, 2016, 1601 (1) : 192 - 192
[29] PembrolizumabMyasthenia gravis with myositis: case report
Reactions Weekly, 2020, 1812 (1) : 232 - 232
[30] PembrolizumabMyasthenia gravis crisis : case report
Reactions Weekly, 2016, 1611 (1) : 140 - 140

← 1 2 3 4 5 →